Regarding liver AQP9, inhibition of AQP9-facilitated glycerol import by hepatocytes [31] may be effective in the prevention of liver steatosis and some of its severe consequences, such as steatohepatitis and cirrhosis [42], or in the control of gluconeogenesis from glycerol in T2D. The gene discussed is AQP9; the disease is type 2 diabetes mellitus.